Phase 4 Relapse Clinical Trials
7 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–7 of 7 trials
Recruiting
Phase 4
Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager
Multiple Myeloma, RefractoryRelapsed Multiple Myeloma
CHU de Quebec-Universite Laval80 enrolled1 locationNCT07094048
Recruiting
Phase 4
Bupropion for the Prevention of Postpartum Smoking Relapse
Postpartum Smoking Relapse
University of Minnesota200 enrolled1 locationNCT04098874
Recruiting
Phase 4
Plan Development for Giving Teclistamab in the Outpatient Setting
Multiple MyelomaRefractory CancerRelapsed Cancer
University Health Network, Toronto15 enrolled1 locationNCT06251076
Recruiting
Phase 4
Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma
Relapsed or Refractory B-cell Lymphoma
Ruijin Hospital8 enrolled1 locationNCT05806580
Recruiting
Phase 4
Clinical Study of OR for Second-line Treatment of Refractory MZL
OR Regimen for Relapsed/Refractory Marginal Zone Lymphoma
Lixia Sheng39 enrolled3 locationsNCT06134284
Recruiting
Phase 4
Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease
TreatmentRelapseGraves Disease+1 more
The First Affiliated Hospital with Nanjing Medical University240 enrolled1 locationNCT05461820
Recruiting
Phase 3Phase 4
Outpatient Ifosfamide, Etoposide plus Rituximab (R-IE) for salvage in patients > 60 years with relapsed or refractory CD20 positive diffuse large B-cell lymphoma who are not candidates for stem cell transplant study
Relapsed or refractory CD20 positive diffuse large B-cell lymphoma
Roche40 enrolled1 locationACTRN12606000373572